NasoShield™ (Single Dose Intranasal Anthrax Vaccine)

An intranasal vaccine designed to provide protection against anthrax after a single administration. It is being developed with the support of the U.S. Biomedical Advanced Research and Development Authority, (BARDA) for post-exposure prophylaxis against anthrax following exposure to aerosolized B. anthracis spores.

Notify me on updates of this product 

Availability: In Development

Jose Ochoa
Chief Business Manager
jochoa@altimmune.com
+1 240 654- 450
910 Clopper Road, Suite 201-S
Gaithersburg, MD 20878
USA
https://altimmune.com/nasoshield/
Manufacturer
Altimmune, Inc.
Product Name
NasoShield™ (Single Dose Intranasal Anthrax Vaccine)
Detection Category
Biological
Detection Method
Medical Countermeasure;
Application
Personal Protective Equipment;
Equipment Type
PPE
Product Synopsis
An intranasal vaccine designed to provide protection against anthrax after a single administration. It is being developed with the support of the U.S. Biomedical Advanced Research and Development Authority, (BARDA) for post-exposure prophylaxis against anthrax following exposure to aerosolized B. anthracis spores.
Availability
In Development
Technology Readiness Level (TRL)
7
User Feedback Sources
Indifferent/No user feedback
Weight
<1 lb.
Transportability
Pocket Size
Live Agent Tested
Yes; B. anthracis (anthrax)
Operating Time
Preventative administration prior to exposure
Training Required
<1 hour training
Please enter contact info.
Email Address: 
Company: 
Name: 
Title: